Health & Environment
Shingles Vaccine Linked to Reduced Cardiovascular Disease Risk
The Pharmaceutical Journal1h
THE BRIEF
1
A study published in Nature Medicine on August 26, 2026, found a 9% reduction in cardiovascular disease burden among recipients of the recombinant shingles vaccine.
2
The Independent Pharmacies Association is urging the government to accelerate the expansion of the shingles vaccination program to all adults aged 60 and over.
3
Current NHS policy in England, Scotland, and Wales offers the vaccine to those turning 65 and specific age groups, with full 60-plus coverage not scheduled until 2033.